Treatment with lutein provides neuroprotection in mice subjected to transient cerebral ischemia

Journal of Asian Natural Products Research

Volumn 16, Issue 11, 2014, Pages 1084-1093

  Sun, Ya Xuan ^a   Liu, Ting ^b   Dai, Xue Ling ^a   Zheng, Qiu Sheng ^b   Hui, Bo Di ^a   Jiang, Zhao Feng ^a  

^a BEIJING UNION UNIVERSITY   (China)

^b SHIHEZI UNIVERSITY   (China)

Author keywords

antioxidant; lutein; neuroprotection; oxidative stress; transient cerebral ischemia

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; PROTEIN; SUPEROXIDE DISMUTASE; XANTHOPHYLL; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN TISSUE; COLORIMETRY; CONTROLLED STUDY; DRUG MEGADOSE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LOW DRUG DOSE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL; NEUROLOGIC DISEASE; NEUROLOGICAL DEFICIT SCORE; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REPERFUSION INJURY; SCORING SYSTEM; TRANSIENT ISCHEMIC ATTACK; TUNEL ASSAY; ANIMAL; CHEMICAL STRUCTURE; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; ISCHEMIC ATTACK, TRANSIENT; METABOLISM; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CATALASE; GLUTATHIONE PEROXIDASE; ISCHEMIC ATTACK, TRANSIENT; LUTEIN; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; NEUROPROTECTIVE AGENTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 84911953710     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286020.2014.939584     Document Type: Article

References (22)

1. S.E. Lakhan, A. Kirchgessner, and M. Hofer, J. Transl. Med. 7, 97 (2009).
2. H. Shi and K.J. Liu, Front Biosci. 12, 1318 (2007).
3. J. Wu, J.G. Hecher, and N. Chiamvimonvat, Adv Drug Deliv. Rev. 61, 351 (2009).
4. I. Margaill, M. Plotkine, and D. Lerouge, Free Radic. Biol. Med. 39, 429 (2005).
5. M.M. Khan, T. Ishrat, A. Ahmad, M.N. Hoda, M.B. Khan, G. Khuwaja, P. Srivastava, S.S. Raza, F. Islam, and S. Ahmad, Chem. Biol. Interact. 183, 255 (2010).
6. A.J. Chucair, N.P. Rotstein, J.P. Sanqiovanni, A. During, E.Y. Chew, and L.E. Politi, Invest. Ophthalmol. Vis. Sci. 48, 5168 (2007).
7. W. Ogura, S. Itagaki, T. Kurokawa, T. Noda, T. Hirano, S. Mizuno, and K. Iseki, Biol. Pharm. Bull. 29, 1764 (2006).
8. S.Y. Li, Z.J. Fu, H. Ma, W.C. Jang, K.F. So, D. Wong, and A.C. Lo, Invest. Ophthalmol. Vis. Sci. 50, 836 (2009).
9. S.Y. Li, D. Yang, J.F. Zhong, T. Woo, D. Wong, and A.C.Y. Lo, Neurobiol. Dis. 45, 624 (2012).
10. C.L. Allen and U. Bayraktutan, Int. J. Stroke 4, 461 (2009).
11. W.L. Jiang, S.P. Zhang, H.B. Zhu, H. Jian, and J.W. Tian, Phytother. Res. 24, 547 (2010).
12. A. Saito, T. Hayashi, S. Okuno, T. Nishi, and P.H. Chan, Stroke 35, 2560 (2004).
13. S. Ha, P. Lee, J.A. Park, H.R. Oh, S.Y. Lee, J.H. Park, E.H. Lee, J.H. Ryu, K.R. Lee, and S.Y. Kim, Neurochem. Int. 52, 878 (2008).
14. N. Xin, F.J. Yang, Y. Li, Y.J. Li, R.J. Dai, W.W. Meng, Y. Chen, and Y.L. Deng, Phytomedicine 21, 68 (2013).
15. Z.H. Wang, T. Liu, L. Gan, T. Wang, X. Yuan, B. Zhang, H. Chen, and Q. Zheng, Eur. J. Pharmacol. 643, 211 (2010).
16. E. Candelario-Jalil, N.H. Mhadu, S.M. Al-Dalain, G. Martínez, and O.S. León, Neurosci. Res. 41, 233 (2001).
17. H.J. Jung, J.H. Nam, J. Choi, K.T. Lee, and H.J. Park, J. Ethnopharmacol. 97, 359 (2005).
18. G.M. Campo, A. Avenoso, S. Campo, A.M. Ferlazzo, C. Micali, L. Zanghí, and A. Calatroni, Life Sci. 74, 1289 (2004).
19. G. Chandra Jagetia, G.K. Rajanikant, S.K. Rao, and M. Shrinath Baliga, Clin. Chim. Acta 332, 111 (2003).
20. D.H. Cao, J.F. Xu, R.H. Xue, W.F. Zheng, and Z.L. Liu, Pharmacol. Biochem. Behav. 79, 651 (2004).
21. R.L. Levine, D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman, Methods Enzymol. 186, 464 (1990).
22. M.M. Bradford, Anal. Biochem. 72, 248 (1976).